News & Insights

News & Insights
Dec
3
//
2021

Aqemia and Servier announce AI and quantum physics-drive drug discovery collaboration in immuno-oncology

News & Insights
Oct
28
//
2021

Aqemia is in the ranking of the 100 start-ups to invest in 2021 according to Challenges

For the twelfth year in a row, the magazine Challenges published its selection of “100 start-ups to invest in”. More than 700 applications have been submitted and 100 start-ups have been selected, including Aqemia.
News & Insights
Oct
19
//
2021

Aqemia receives France Biotech award for AI in HealthTech

We're proud to announce Aqemia receives France Biotech award for AI in HealthTech. This award echoes recent milestones with top pharmas in the US and Europe and Aqemia's seeding of a massive, scalable, internal drug discovery pipeline.
News & Insights
Sep
7
//
2021

Aqemia has a brand new office in the center of Paris

Aqemia has brand new offices to sustain rapid growth and expansion. At our deeptech incubator Agoranov, We grew from 2 to 20 in 18 months. Our new offices located in the nice 15th arrondissement of Paris will allow us an increase of... 100% in the next 12 months.
News & Insights
Jun
14
//
2021

Aqemia joined Sanofi booth at VivaTechnology

Aqemia was present at Viva Technology, Europe biggest start up and tech event! Thank you Sanofi for inviting us. We’re also very proud of our partnership.
News & Insights
Feb
22
//
2021

Aqemia participated in latest report about Nature co-design by Hello Tomorrow and Boston Consulting Group (BCG)

Aqemia gave input and insights alongside other companies for the report. It is about nature co-design, explaining how, for the first time in history, we can use nature as an engineering and manufacturing platform at the atomic level.

@ElasticThemes